Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients

Clinical Nephrology

Volumn 79, Issue 1, 2013, Pages 21-30

  Ozkok, Abdullah ^a   Aktas, Esin ^b   Yilmaz, Akar ^c   Telci, Aysegul ^a   Oflaz, Huseyin ^c   Deniz, Gunnur ^b   Yildiz, Alaattin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Inst for Exp Medical Research   (Turkey)

^c Department of Cardiology ^*  (Turkey)

Author keywords

Atherosclerosis; Endothelial dysfunction; Endothelial progenitor cell; Flow mediated dilatation; Hemodialysis; Inflammation

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; CELL MARKER; FIBRONECTIN; INTERCELLULAR CELL ADHESION MOLECULE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLOW MEDIATED DILATATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CELL COUNT; CELLS, CULTURED; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RENAL DIALYSIS; STEM CELLS; UREMIA;

EID: 84873732151     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107318     Document Type: Article

References (32)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32 (Suppl 3): S112-S119.
2. Goldsmith DJ, Covic A. Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int. 2001; 60: 2059-2078.
3. Ishimura E, Shoji T, Emoto M, Motoyama K, Shinohara K, Matsumoto N, Taniwaki H, Inaba M, Nishizawa Y. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis. 2001; 38 (Suppl 1): S186-S190.
4. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med. 2006; 10: 318-332.
5. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348: 593-600.
6. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353: 999-1007.
7. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 2004; 24: 1246-1252.
8. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 2004; 66: 641-646.
9. Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis. 2006; 65: 157-163.
10. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004; 110: 1209-1212.
11. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart. 2007; 93: 1064-1070.
12. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rössig L, Corbaz A, Chvatchko Y, Zeiher AM, Dimmeler S. p38 mitogen- activated protein kinase downregulates endothelial progenitor cells. Circulation. 2005; 111: 1184-1191.
13. Balestrieri ML, Giovane A, Milone L, Felice F, Fiorito C, Crudele V, Esposito A, Rossiello R, Minucci PB, Farzati B, Servillo L, Napoli C. Modification of the detrimental effect of TNF-a on human endothelial progenitor cells by fasudil and Y27632. J Biochem Mol Toxicol. 2010; 24: 351-360.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJChamber Quantification Writing GroupAmerican Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463.
15. Balbarini A, Buttitta F, Limbruno U, Petronio AS, Baglini R, Strata G, Mariotti R, Ciccone M, Mariani M. Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease. Angiology. 2000; 51: 269-279.
16. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340: 1111-1115.
17. Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR, Haine SE, Vermeulen K, Van Tendeloo VF, Vrints CJ, Hoymans VY. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J Immunol Methods. 2008; 332: 31-40.
18. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001; 89: E1-E7.
19. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost. 2009; 7 (Suppl 1): 49-52. doi:10.1111/j.1538-7836.2009.03407.x PubMed
20. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008; 28: 1584-1595. doi:10.1161/ATVBAHA. 107.155960 PubMed
21. Roberts MA, Hare DL, Ratnaike S, Ierino FL. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis. 2006; 48: 341-360.
22. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ. C- reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between Creactive protein and cardiovascular disease. Circulation. 2004; 109: 2058-2067. doi:10.1161/01.CIR.0000127577.63323.24 PubMed
23. Suh W, Kim KL, Choi JH, Lee YS, Lee JY, Kim JM, Jang HS, Shin IS, Lee JS, Byun J, Jeon ES, Kim DK. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun. 2004; 321: 65-71.
24. Surdacki A, Marewicz E, Wieteska E, Szastak G, Rakowski T, Wieczorek-Surdacka E, Dudek D, Pryjma J, Dubiel JS. Association between endothelial progenitor cell depletion in blood and mild-tomoderate renal insufficiency in stable angina. Nephrol Dial Transplant. 2008; 23: 2265-2273.
25. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol. 2005; 289: F679-F684.
26. Krieter DH, Fischer R, Merget K, Lemke HD, Morgenroth A, Canaud B, Wanner C. Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy. Nephrol Dial Transplant. 2010; 25: 4023-4031.
27. Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez-Lara MA, Rodríguez M, Martin-Malo A, Tetta C, Aljama P. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int. 2007; 72: 108-113.
28. Liao YF, Chen LL, Zeng TS, Li YM, Fan Yu, Hu LJ, Ling Yue. Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med. 2010; 15: 279-285. Published online May 28, 2010.
29. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005; 45: 1441-1448.
30. Pelliccia F, Pasceri V, Cianfrocca C, Vitale C, Speciale G, Gaudio C, Rosano GM, Mercuro G. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo- controlled study. Atherosclerosis. 2010; 210: 510-515.
31. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, Goldschmidt-Clermont PJ, Dong C, Taylor DA, Peterson ED. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J. 2006; 152: 190-195.
32. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke. 2006; 37: 2277-2282.